Skip to main content
# Title Department Research Member Research Year
21 Safety and Efficacy of Outpatient Management Strategy for Low-Risk Febrile Neutropenia in Pediatric Oncology: A Tertiary Care Experience in Egypt Department of Pediatric Oncology Basma Mahmoud Ismaeel 2025
22 The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study Department of Pathology Dr. Shimaa Hassan Shabaan Hassan 2025
23 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2025
24 The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study Department of Pathology Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2025
25 Expression of TIGIT on NK cells in patients with chronic myeloid leukemia Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2025
26 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2024
27 Prognostic significance of CD3+ and CD8+ T-cells immunoscore in renal cell carcinoma: A comparison between two simple models for assessment Department of Pathology Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2024
28 Role of Irreversible Electroporation in Solid Abdominal Tumors Management Department of Radiology Prof. Amro Farouk ِAhmedMourad 2024
29 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Amany Mohammed Abdel Moatamed 2024
30 Factors affecting timing of hypothyroidism following radioactive iodine therapy (RAIT) for patients with Graves' disease: A 12-month observational study Department of Radiotherapy and Nuclear medicine Dr. Esraa Roshdy Hassan Mohamed 2024